PSFE vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

PSFE

48.0
AI Score
VS
PSFE Wins

CLOV

44.3
AI Score

Investment Advisor Scores

PSFE

48score
Recommendation
HOLD

CLOV

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PSFE CLOV Winner
Forward P/E 3.1162 37.7358 PSFE
PEG Ratio 0 0 Tie
Revenue Growth 4.5% 55.6% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 48.0/100 44.3/100 PSFE
Profit Margin -11.8% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PSFE 1M: -12.5% · 3M: -35.3% CLOV 1M: -1.6% · 3M: -19.6%

Current Technical Phase

PSFE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.5 · Price: $5.44

CLOV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 41

RSI (14): 41.5 · Price: $4.23

Fundamentals Snapshot

Metric PSFE CLOV
Market Cap — —
Forward P/E 2.5 28.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.6%
Gross Margin 0.6% 0.2%
Operating Margin 0.0% 0.0%
EPS -3.65 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PSFE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.